City
Epaper

Two indigenous candidate COVID-19 vaccines get DCGI nod to start early phase human trials

By ANI | Updated: July 14, 2020 19:35 IST

Two indigenous candidate vaccines for COVID-19 have got DCGI clearance to start early phase human trials in the country, the Indian Council of Medical Research (ICMR) said on Tuesday.

Open in App

Two indigenous candidate vaccines for COVID-19 have got DCGI clearance to start early phase human trials in the country, the Indian Council of Medical Research (ICMR) said on Tuesday.

"There are two Indian indigenous candidate vaccines. They have undergone successful toxicity studies in rats, mice and rabbits. The data was submitted to DCGI following which both these got clearance to start early phase human trials early this month," said Dr Balram Bhargava, DG-ICMR at a daily press briefing here.

"They have got their sites ready and they are doing their clinical study on approximately a thousand volunteers each at different sites," he added.

Bhargava said that experiments for the two vaccines, among others, are also being done at NIV, Pune and spoke about the various programmes being carried out to develop a vaccine globally.

"Recently, Russia has fast-tracked a vaccine which has been successful in the early phases and they have fast-tracked its development. The whole world has applauded it and congratulated Russia. China has also fast-tracked its vaccine programme and fast-tracked its studies with vaccines. The US has again fast-tracked two of its vaccine candidates and the UK is also looking at how it can fastrack the Oxford vaccine candidate," Bhargava said.

He added that India supplies over 60 per cent of the vaccines for various diseases to countries around the world and said that it makes India's role a key one in the race to prepare and supply a COVID-19 vaccine to the world.

"India is considered as the pharmacy of the world. 60 per cent of the drugs utilised in the US are of Indian origin. The other fact which is not well known is that 60 percent of vaccines supplied around the world are of Indian origin, so India is perceived and is well known for vaccine supply in the world," Bhargava said.

"Any vaccine produced in any party part of the world will ultimately have to be scaled up by India or by China. Because these are the two major vaccine producers of the world. Everyone who is trying to prepare a vaccine is in talks with India," he further said.

( With inputs from ANI )

Tags: puneOxfordIndian Council Of Medical ResearchIcmrBalram BhargavaIndia council of medical researchIndian council of medicalIndian council medical researchIndian council for medicalMumbai pune
Open in App

Related Stories

PunePune Accident: One Woman Killed, Dozens Injured as Pickup Overturns and Falls into Ditch in Junnar

PunePune Accident: One Dead, Another Critically Injured as Car Falls into Pit on Bhor-Mahad Road

PunePune-Solapur Highway Accident: One Dead in Tempo Collision Near Vakhari Village; Horrific Crash Caught on CCTV (Watch Video)

PunePune Cyber Fraud: Two People Duped of Rs 22.2 Lakh by Stock Market Scam

PunePune Crime: 3 Women from Same Family Arrested for Selling Ganja

National Realted Stories

NationalKarur stampede case: Three special TN Police teams formed to arrest TVK's Bussy Anand

NationalDelhi Police nab robbery accused after 12-year manhunt

NationalRBI slashes inflation forecast to 2.6 pc in FY26 over GST reforms, benign food prices

NationalKerala Police file charge sheet against Malayalam rapper Vedan in rape case

NationalMoney Rules Change From October 1: LPG, UPI, Rail Tickets, and More to Impact Daily Life